Biophytis Raises €1.5M in Private Placement
| Field | Detail |
|---|---|
| Company | Biophytis SA |
| Form Type | 6-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: private-placement, funding, clinical-trials
TL;DR
Biophytis just snagged €1.5M from a private placement to fund its clinical trials.
AI Summary
On July 3, 2025, Biophytis S.A. announced the successful completion of a private placement, raising approximately €1.5 million (approximately $1.6 million USD) before expenses. The funds will be used for general corporate purposes, including the advancement of its clinical programs. The placement involved the issuance of 1,500,000 ordinary shares at a price of €1.00 per share.
Why It Matters
This capital raise provides Biophytis with crucial funding to continue its research and development efforts, potentially advancing its drug candidates towards regulatory approval and market entry.
Risk Assessment
Risk Level: medium — While the capital raise is positive, the relatively small amount and the use for general corporate purposes suggest ongoing funding needs and potential dilution risks for shareholders.
Key Numbers
- €1.5M — Capital Raised (Funds secured through a private placement to support corporate activities and clinical programs.)
- 1,500,000 — Shares Issued (Number of ordinary shares placed in the private offering.)
- €1.00 — Price Per Share (The price at which each ordinary share was issued in the private placement.)
Key Players & Entities
- Biophytis S.A. (company) — Registrant and issuer of shares
- Stanislas Veillet (person) — Contact person for Biophytis S.A.
- €1.5 million (dollar_amount) — Amount raised in private placement
- $1.6 million USD (dollar_amount) — Approximate USD equivalent of funds raised
- July 3, 2025 (date) — Date of press release announcing private placement
- 1,500,000 ordinary shares (share_count) — Number of shares issued in private placement
- €1.00 (dollar_amount) — Price per share in private placement
FAQ
What was the total amount raised by Biophytis S.A. in its recent private placement?
Biophytis S.A. raised approximately €1.5 million (before expenses) in its private placement.
On what date did Biophytis S.A. announce the completion of its private placement?
The company announced the successful completion of the private placement on July 3, 2025.
How many ordinary shares were issued in the private placement?
A total of 1,500,000 ordinary shares were issued in the private placement.
At what price were the ordinary shares issued in the private placement?
The ordinary shares were issued at a price of €1.00 per share.
What is the intended use of the funds raised by Biophytis S.A.?
The funds raised are intended for general corporate purposes, including the advancement of its clinical programs.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 9, 2025 by Stanislas Veillet regarding Biophytis SA.